Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean M Jasinski

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|April 12, 2005
Hypothesis for the pathogenesis of type 1A diabetesJean M Jasinski, George S Eisenbarth
Endocrinology and Metabolism Clinics of North America|April 1, 2004
Disease prevention with islet autoantigensGeorge S Eisenbarth, Jean M Jasinski
Diabetes|June 29, 2006
Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockoutJean M Jasinski, Liping Yu, Maki Nakayama, et al.
Journal of Translational Medicine|February 29, 2012
Congruence as a measurement of extended haplotype structure across the genomeErin E Baschal, Jean M Jasinski, Theresa A Boyle, et al.
Journal of Autoimmunity|March 17, 2009
Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chainsLi Zhang, Jean M Jasinski, Masakazu Kobayashi, et al.
Clinical Immunology (Orlando, Fla.)|May 12, 2009
Defining multiple common "completely" conserved major histocompatibility complex SNP haplotypesErin E Baschal, Theresa A Aly, Jean M Jasinski, et al.
The Journal of Clinical Investigation|July 4, 2007
Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunityMaki Nakayama, Joshua N Beilke, Jean M Jasinski, et al.
Journal of Diabetes|June 3, 2011
Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complexErin E Baschal, Suparna A Sarkar, Theresa A Boyle, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drugs of Today (Barcelona, Spain : 1998)|April 12, 2005
Hypothesis for the pathogenesis of type 1A diabetesJean M Jasinski, George S Eisenbarth
Endocrinology and Metabolism Clinics of North America|April 1, 2004
Disease prevention with islet autoantigensGeorge S Eisenbarth, Jean M Jasinski
Diabetes|June 29, 2006
Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockoutJean M Jasinski, Liping Yu, Maki Nakayama, et al.
Journal of Translational Medicine|February 29, 2012
Congruence as a measurement of extended haplotype structure across the genomeErin E Baschal, Jean M Jasinski, Theresa A Boyle, et al.
Journal of Autoimmunity|March 17, 2009
Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chainsLi Zhang, Jean M Jasinski, Masakazu Kobayashi, et al.
Clinical Immunology (Orlando, Fla.)|May 12, 2009
Defining multiple common "completely" conserved major histocompatibility complex SNP haplotypesErin E Baschal, Theresa A Aly, Jean M Jasinski, et al.
The Journal of Clinical Investigation|July 4, 2007
Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunityMaki Nakayama, Joshua N Beilke, Jean M Jasinski, et al.
Journal of Diabetes|June 3, 2011
Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complexErin E Baschal, Suparna A Sarkar, Theresa A Boyle, et al.
Pageof 1